ERBB2 and breast cancer: TNBC is a subgroup (~15%) of breast cancer that is not be amenable to hormonal-based therapeutics available for the larger group of breast cancers that express estrogen and/or progesterone, or for those that have elevated human epidermal growth factor-2-(HER2) production [119].